{"transactions":[{"id":4619883,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":19111,"kind":"person","name":"Trenor Cameron C. III","position":1,"cik":"0002150478","reported_name":"Trenor Cameron C. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to by)","published_at":"2026-09-16T21:35:25.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":233333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option vest as follows: 25% of the shares vest on August 24, 2027 and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":233333,"derivative":{"exercise_price":5.36,"expiration_date":"2036-09-14","underlying":"Common Stock","underlying_shares":233333},"source":{"system":"sec-edgar","filing":"0001193125-26-393274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2150478/000119312526393274/ownership.xml","form_type":"4"}},{"id":4619882,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":19111,"kind":"person","name":"Trenor Cameron C. III","position":1,"cik":"0002150478","reported_name":"Trenor Cameron C. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-16T21:35:25.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":116667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which vest as follows: 10,400 RSUs vest on January 1, 2027, prorated from August 24, 2026, the vesting start date, and the remaining RSUs vest in equal annual installments on each January 1, 2028, January 1,  2029 and January 1, 2030, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":116667,"source":{"system":"sec-edgar","filing":"0001193125-26-393274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2150478/000119312526393274/ownership.xml","form_type":"4"}}]}